Weiyi Li

Senior Manager, LNP Formulation at Prime Medicine

Speaker

Weiyi Li is currently a Senior Manager of LNP Formulation at Prime Medicine, where she leads efforts in advancing lipid nanoparticle (LNP) delivery systems for Prime Editing. Her work spans formulation development, process optimization, scale-up, and CMC strategy to support the therapeutic potential of gene editing technologies. She earned her Ph.D. in Materials Science and Chemical Engineering from Stony Brook University in 2019. Prior to joining Prime Medicine, Dr. Li was a scientist at Phosphorex, where she focused on the development of micro- and nanomaterials for diverse drug delivery applications.